Steven T Leach1, Kei Lui2,3, Zin Naing4, Scot E Dowd5, Hazel M Mitchell6, Andrew S Day2,7. 1. School of Women's and Children's Health, University of New South Wales, High Street, Sydney, NSW, 2031, Australia. s.leach@unsw.edu.au. 2. School of Women's and Children's Health, University of New South Wales, High Street, Sydney, NSW, 2031, Australia. 3. Department of Newborn Care, Royal Hospital for Women, Sydney, Australia. 4. Virology, Department of Microbiology, South Eastern Area Laboratory Services, Prince of Wales Hospital, Sydney, Australia. 5. Molecular Research LP, MR DNA, Shallowater, TX, USA. 6. School of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, Australia. 7. Department of Paediatrics, University of Otago, Christchurch, New Zealand.
Abstract
BACKGROUND: Necrotizing enterocolitis (NEC) leads to significant morbidity and mortality in the neonatal intensive care unit. Although current evidence would suggest that bacteria contribute to the pathogenesis of NEC, no single bacterium has yet been identified. AIMS: The aims of this study were to investigate fecal S100A12 concentrations and the intestinal bacterial community in premature infants (24-32 weeks) and investigate any associations between the microbiota and the development of NEC. METHODS: Meconium and feces were collected from premature newborn infants (between 24 and 32 weeks gestation) over the first 4 weeks of life. Fecal S100A12 concentrations were assayed by immunoassay, and samples were subject to 16S rDNA analysis using next-generation sequencing techniques. RESULTS: Fecal samples were collected from four infants that developed NEC and 18 control infants. Prior to developing NEC, fecal S100A12 concentrations were not elevated; however, following NEC diagnosis, concentrations were highly elevated. The fecal bacterial communities of infants with NEC did not differ significantly from control infants. However, potentially pathogenic bacteria were detected in significantly more infants with NEC than in controls (p = 0.0007). CONCLUSION: At birth, fecal S100A12 concentrations were not elevated in premature infants subsequently developing NEC in this cohort. Following NEC diagnosis, S100A12 concentrations were highly elevated, suggesting that this potentially could act as a marker of disease progression. Higher detection rates of potentially pathogenic bacteria in NEC infants suggest that a range of potentially pathogenic bacteria may collectively contribute to NEC pathogenesis.
BACKGROUND:Necrotizing enterocolitis (NEC) leads to significant morbidity and mortality in the neonatal intensive care unit. Although current evidence would suggest that bacteria contribute to the pathogenesis of NEC, no single bacterium has yet been identified. AIMS: The aims of this study were to investigate fecal S100A12 concentrations and the intestinal bacterial community in premature infants (24-32 weeks) and investigate any associations between the microbiota and the development of NEC. METHODS: Meconium and feces were collected from premature newborn infants (between 24 and 32 weeks gestation) over the first 4 weeks of life. Fecal S100A12 concentrations were assayed by immunoassay, and samples were subject to 16S rDNA analysis using next-generation sequencing techniques. RESULTS: Fecal samples were collected from four infants that developed NEC and 18 control infants. Prior to developing NEC, fecal S100A12 concentrations were not elevated; however, following NEC diagnosis, concentrations were highly elevated. The fecal bacterial communities of infants with NEC did not differ significantly from control infants. However, potentially pathogenic bacteria were detected in significantly more infants with NEC than in controls (p = 0.0007). CONCLUSION: At birth, fecal S100A12 concentrations were not elevated in premature infants subsequently developing NEC in this cohort. Following NEC diagnosis, S100A12 concentrations were highly elevated, suggesting that this potentially could act as a marker of disease progression. Higher detection rates of potentially pathogenic bacteria in NEC infants suggest that a range of potentially pathogenic bacteria may collectively contribute to NEC pathogenesis.
Authors: T Z DeSantis; P Hugenholtz; N Larsen; M Rojas; E L Brodie; K Keller; T Huber; D Dalevi; P Hu; G L Andersen Journal: Appl Environ Microbiol Date: 2006-07 Impact factor: 4.792
Authors: Michael T Bailey; Scot E Dowd; Nicola M A Parry; Jeffrey D Galley; David B Schauer; Mark Lyte Journal: Infect Immun Date: 2010-02-09 Impact factor: 3.441
Authors: Stefanie Handl; Scot E Dowd; Jose F Garcia-Mazcorro; Jörg M Steiner; Jan S Suchodolski Journal: FEMS Microbiol Ecol Date: 2011-02-14 Impact factor: 4.194
Authors: Renato Andreotti; Adalberto A Pérez de León; Scot E Dowd; Felix D Guerrero; Kylie G Bendele; Glen A Scoles Journal: BMC Microbiol Date: 2011-01-06 Impact factor: 3.605
Authors: Sydney M Finegold; Scot E Dowd; Viktoria Gontcharova; Chengxu Liu; Kathleen E Henley; Randall D Wolcott; Eunseog Youn; Paula H Summanen; Doreen Granpeesheh; Dennis Dixon; Minghsun Liu; Denise R Molitoris; John A Green Journal: Anaerobe Date: 2010-07-09 Impact factor: 3.331
Authors: Yunwei Wang; Jeanette D Hoenig; Kathryn J Malin; Sanaa Qamar; Elaine O Petrof; Jun Sun; Dionysios A Antonopoulos; Eugene B Chang; Erika C Claud Journal: ISME J Date: 2009-04-16 Impact factor: 10.302
Authors: Christian Milani; Sabrina Duranti; Francesca Bottacini; Eoghan Casey; Francesca Turroni; Jennifer Mahony; Clara Belzer; Susana Delgado Palacio; Silvia Arboleya Montes; Leonardo Mancabelli; Gabriele Andrea Lugli; Juan Miguel Rodriguez; Lars Bode; Willem de Vos; Miguel Gueimonde; Abelardo Margolles; Douwe van Sinderen; Marco Ventura Journal: Microbiol Mol Biol Rev Date: 2017-11-08 Impact factor: 11.056
Authors: Jacob A F Westaway; Roger Huerlimann; Catherine M Miller; Yoga Kandasamy; Robert Norton; Donna Rudd Journal: Matern Health Neonatol Perinatol Date: 2021-03-08
Authors: Debi M Thomas; Brandon Bell; Stephanie Papillon; Patrick Delaplain; Joanna Lim; Jamie Golden; Jordan Bowling; Jin Wang; Larry Wang; Anatoly V Grishin; Henri R Ford Journal: PLoS One Date: 2017-11-30 Impact factor: 3.240
Authors: Alexandre Carvalho; Jacky Lu; Jamisha D Francis; Rebecca E Moore; Kathryn P Haley; Ryan S Doster; Steven D Townsend; Jeremiah G Johnson; Steven M Damo; Jennifer A Gaddy Journal: Gastroenterol Res Pract Date: 2020-02-26 Impact factor: 2.260